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Abstract: Quantitative measures of radiation-induced breast stiffness are required to support clini-
cal studies of novel breast radiotherapy regimens and exploration of personalised therapy, however, 
variation between shear-wave elastography (SWE) machines may limit the usefulness of shear-wave 
speed (cs) for this purpose. Mean cs measured in four healthy volunteers’ breasts and a phantom 
using 2D-SWE machines Acuson S2000 (Siemens Medical Solutions) and Aixplorer (Supersonic Im-
agine) were compared. Shear-wave speed was measured in the skin region, subcutaneous adipose 
tissue and parenchyma. cs estimates were on average 2.3% greater when using the Aixplorer com-
pared to S2000 in vitro. In vivo, cs estimates were on average 43.7%, 36.3% and 49.9% significantly 
greater (p << 0.01) when using the Aixplorer compared to S2000, for skin region, subcutaneous adi-
pose tissue and parenchyma, respectively. In conclusion, despite relatively small differences be-
tween machines observed in vitro, large differences in absolute measures of shear wave speed meas-
ured were observed in vivo, which may prevent pooling of cross-machine data in clinical studies of 
the breast. 
Keywords: shear-wave elastography; shear-wave speed; radiation-induced breast toxicity; tissue 
stiffness; cross-machine comparison 
 
1. Introduction 
Breast-conserving surgical local excision, followed by radiotherapy (RT) to improve 
local control and survival, is a successful treatment for early breast cancer. Approximately 
31,000 women receive adjuvant breast RT in the UK per year with local relapse rates as 
low as ~6% at 10 years [1]. Given that many women are now surviving decades beyond 
their breast cancer treatment, a priority now is to reduce the long-term side effects of ra-
diotherapy to the breast. The overall cosmetic outcome has been shown to be an important 
factor influencing patient psychosocial morbidity after treatment [2]. Evaluation of novel 
RT regimens must weigh the positive outcomes (including local control, disease-free sur-
vival, and overall survival) against treatment-related toxicity and the impact on the pa-
tient’s quality of life. Currently, morbidity-related endpoints are primarily derived from 
subjective measures of function, patient comfort and cosmesis, as evaluated by clinicians 
or patients, which can be subject to variation due to psychological and social factors [3,4]. 
Such variation may preclude the pooling of results from multiple clinical studies of radi-
otherapy [5], required to support studies of genetic predisposition to radiation toxicity 
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[6]. Quantitative, reproducible measures of morbidity could remove these sources of var-
iation allowing more objective assessment of treatment toxicity and facilitating explora-
tion of personalised treatment. 
Shear-wave elastography (SWE) has the potential to quantify tissue stiffness for the 
purpose of disease diagnosis, prognosis or staging, and to monitor the response of tissues 
to treatment [7–12]. SWE is expected to be able to quantify properties related to breast 
tissue stiffness using shear-wave speed cs, which under a number of assumptions is re-
lated to Young’s modulus (E) of the tissue using E = 3  cs2, where   is tissue density [10]. 
Absolute or relative measures of cs or E may be useful. One such relative measure could 
be the spatial distribution of cs, which can be compared with the radiation dose distribu-
tion delivered to the patient, potentially helping to further increase understanding of the 
relationship between dose and radiation-induced morbidity. Two-dimensional SWE (2D-
SWE) which provides the spatial distribution, or map, of cs may be used for this purpose. 
Here, we adopt the convention for describing different forms of elastography outlined in 
Bamber et al. [13]. 
In the context of large multi-centre clinical trials, required to provide the clinical ev-
idence to change practice [1], measures of morbidity must be reproducible between cen-
tres. There is evidence to suggest that cs estimates vary between machines provided by 
different vendors, transducer types and imaging depth [14–16]. This may detrimentally 
affect the application of SWE to the assessment of normal tissue toxicity because it is un-
likely that the same SWE equipment will be available across different clinical centres. 
Investigations that compare cs estimates made with various machines, transducers 
and system settings have been largely limited to in vitro studies [17–19], albeit with some 
in the liver in vivo [20,21]. No study has compared cs estimates between machines in nor-
mal breast tissues. The purpose of the current study was to compare absolute and relative 
measures of breast cs between 2D-SWE machines in vivo to determine if these could be 
used as reliable metrics in planned cross-centre and cross-machine clinical studies of ra-
diation-induced fibrosis. Previous work has shown that the skin thickens post radiother-
apy [22,23] and other work has indicated that women with greater breast size are more 
likely to experience breast hardening [24,25]. Larger breast size is associated with a greater 
proportion of adipose tissue. It may therefore be important to measure hardening in com-
ponent breast tissues, i.e., skin, adipose and breast parenchyma. It is expected that differ-
ent breast tissues will have different cs [26–28] and that these differences are consistent 
between machines. Previous studies of point SWE (pSWE) suggest that cs estimates are 
influenced by transducer orientation with respect to Cooper’s ligaments [28]. If 2D-SWE 
cs estimates are similarly affected, care must be taken to reproduce transducer orientation 
across centres. 
In this study, we investigate the difference in cs measured using two machines that 
provide 2D-SWE, the Aixplorer®  (Supersonic Imagine, Aix-en-Provence, France) and the 
Acuson S2000®  (Siemens Healthcare GmbH, Erlangen, Germany). Both machines generate 
shear waves in tissue using an acoustic radiation force impulse (ARFI), which creates a 
local tissue displacement at the focus of the ARFI beam. This small displacement of tissue 
generates shear waves that emanate from the focus. Although the approach to measuring 
cs is similar there may be technical differences that lead to a variation in the value of cs 
measured. For example, the Acuson builds up a 2D image by focusing the ARFI beam at 
multiple lateral locations at multiple depths. The shear waves are tracked using multiple 
tracking beams [13,29]. The Aixplorer uses a different approach, sweeping the ARFI focus 
over the depth of imaging faster than the speed of the shear waves, generating a cone-
shaped shear wave, known as a Mach cone. This scanner tracks the propagation of the 
shear wave using ultrafast plane wave imaging, allowing the shear waves to be tracked 
in 2D [30]. Furthermore, each machine uses proprietary software to generate values of cs 
using the tracking data. Consequently, differences in how the displayed value of cs is cal-
culated may also exist. 
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Variation between absolute measures of mean cs values was investigated in different 
regions of the breast, specifically, the skin region, subcutaneous adipose tissue and, where 
it could be clearly differentiated, breast parenchyma. Relative measures investigated in-
cluded tissue cs ratio, the ratio of cs, in pairs of the above tissue types and the anisotropy 
ratio, the ratio of cs estimates acquired in transducer orientations that were radial and anti-
radial with respect to the nipple. 
2. Materials and Methods 
2.1. Machines and Machine Settings 
Cross-centre and cross-machine shear-wave speed (cs) measurements were per-
formed on an ultrasound elasticity phantom and four healthy female volunteers at two 
centres, the Royal Marsden National Health Service (NHS) Foundation Trust (RM) and 
Cambridge University Hospitals NHS Foundation Trust (CUH), on the same day. At RM, 
the Aixplorer®  was used with an L10-2 linear probe and at CUH the Acuson S2000®  with 
Virtual Touch Imaging Quantification (VTIQ® ) technology and a 9L4 linear probe was 
used. Both machines produce a 2D elastogram, i.e., a map of cs. The machine settings for 
the Aixplorer for B-Mode imaging were “Gen/Med”, dynamic range = 61 dB, image per-
sistence = medium, speed of sound = 1540 ms−1, transmit frequency = 5 MHz and, for shear-
wave elastography (SWE) mode, Penetration = Med, SWE map persistence level = high, 
Smoothing = 5 and G = 70%. At CUH, the S2000 settings for B-mode imaging were F = 9 
MHz, dynamic range = 65 dB, speed of sound = 1540 m/s, persistence setting = 3. A maxi-
mum elastogram depth of 3.5 cm was used for both machines. 
2.2. In Vitro Measurements 
A tissue-mimicking phantom (Model 049 Elasticity QA Phantom, Computerized Im-
aging Reference Systems Inc. (CIRS), Norfolk, VA, USA) was used to obtain cs estimates. 
The phantom was made of Zerdine polymer and contained two groups of four spherical 
inclusions of four different elastic moduli different to the elastic modulus of the back-
ground material; one group was placed at a depth of 15 mm and the other at a depth of 
35 mm, the former group was used in this study. 
Three independent observers acquired shear-wave elastograms and cs estimates from 
the four shallow inclusions (depth = 1.5 cm, diameter = 1.0 cm) and background material 
with both machines; deeper inclusions were too deep to fully visualise in SWE mode using 
the linear transducers used in the current study, which are designed for breast examina-
tions. To determine Aixplorer cs estimates within the inclusions, circular regions of interest 
(ROIs), called Q-Boxes, with a diameter of 1.0 cm were positioned over each inclusion and 
cs estimates were recorded. The S2000 cs estimates were acquired using nine 1.5 mm × 1.5 
mm square (fixed by the manufacturer) ROIs positioned randomly within each inclusion 
and within the background material and cs estimates were recorded. For both machines, 
all ROIs were positioned using the B-mode image, except for Aixplorer when artefacts 
were excluded and the elastogram was used to indicate the position of the artefacts. The 
artefacts are discussed in more detail in Section 2.4. Observers independently performed 
measurements three times and were blinded to the results of other observers. 
2.3. In Vivo Imaging 
Four healthy female volunteers with no history of breast malignancy were recruited 
for this study. The Surrey and South East Coast National Health Service Research Ethics 
Committee approved the study and informed consent was obtained from all the volun-
teers prior to scanning. Volunteers were aged 60, 38, 28 and 25 years on the date of scan-
ning. A single consultant breast radiologist (RS at CUH, or EO at RM) acquired elasto-
grams of the breast at each centre. Prior to acquiring data for analysis, radiologists prac-
tised acquiring elastograms without precompression, which may produce an overestima-
tion of cs and introduce SWE elastogram artefacts in vivo [31]. To avoid precompression, 
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copious amounts of ultrasonic gel were used to create a stand-off. Volunteers were asked 
to hold their breath to make it easier to maintain this stand-off during each image acqui-
sition and reduce the likelihood of motion artefacts. 
Images were obtained first with the Aixplorer at RM, after which volunteers travelled 
to CUH and the imaging was repeated with the S2000. There was an average of six hours 
between scanning at the two centres. Eight images were acquired from each breast with 
the transducer in radial and anti-radial transducer orientations, as explained by Figure 1. 
The transducer positions employed at RM were marked using a surgical marker pen to 
enable interrogation of the same regions of tissue at CUH. Volunteers were scanned su-
pine with their arm raised behind their head. B-mode images and elastograms were ac-
quired using the technique described above. 
 
Figure 1. Schematic of transducer positions used to obtain shear-wave speed (cs) estimates from the 
breast. Eight B-mode image and elastogram pairs were acquired from each breast. 
2.4. Shear-Wave Speed Estimates 
The S2000 generated a shear-wave speed grayscale elastogram adjacent to the B-
mode image. See Figure 2a. A radiologist (RS) used the B-mode image to identify skin, 
adipose and parenchyma. Six ROIs were placed on each tissue type on the B-mode image. 
The S2000 provided on-screen annotations showing the position of each region of interest 
(ROI) in both the B-mode and the elastograms, and the mean cs within the ROI. 
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Figure 2. Showing: (a) An example B-mode image/elastogram pair acquired using the S2000 with ROIs marked on skin 
and parenchyma tissues (Volunteer 2); (b) an Aixplorer elastogram containing artefacts, overlaid with transparency on a 
B-mode image (Volunteer 2). In this example, cs values were estimated by placing ROIs (Q-boxes) in the regions free from 
artefacts; (c) the same image where the ROIs were positioned without knowledge of the position of the artefacts, achieved 
by reducing the opacity of the displayed elastogram to zero. Note that the Aixplorer only displays the last 4 ROIs selected. 
The Aixplorer provided an elastogram superimposed on the B-mode image where 
red and blue indicated greater and lesser cs, respectively, as shown in Figure 2b. The small-
est available ROI, 2 mm in diameter, was placed at six different locations on the skin, 
adipose and parenchyma, respectively. The anatomical regions of interest and the cs meas-
urement points selected by the radiologist and annotated on S2000 images were used to 
guide the placement of the ROIs on Aixplorer elastograms, which was performed by EH. 
Image artefacts of high cs at regularly spaced intervals were observed in Aixplorer 
elastograms. These are visible as a regular pattern of greater shear wave speed in Figure 
2b and as vertical lines of greater shear wave speed illustrated using an elastogram of a 
homogenous region of the phantom in Figure 3a. To study the effect of this artefact, the 
Aixplorer analysis was performed twice, once by choosing measurement locations that 
avoided the artefacts using both the B-mode image and the elastogram to position the 
ROIs, as in Figure 2b, and once with measurement locations selected using only the B-
mode image by increasing the cs scale and reducing the opacity of the on-screen display 
of the elastogram to zero (see Figure 2c). In some elastograms, it was not possible to avoid 
some overlap of ROIs with regions that appeared to contain artefacts. In some cases, min-
imising the inclusion of artefacts reduced the number of measurement positions available. 
The number of cs estimates obtained using the Aixplorer when avoiding artefacts varied 
between two and six. 
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Figure 3. Showing: (a) Aixplorer image of a homogenous region of the phantom to illustrate the bands of greater shear 
wave speed (artefacts) observed. (b) Example elastograms of the lesions contained within the CIRS 049 phantom using the 
Aixplorer and the S2000. Nominal shear-wave speeds are given below the images. 
2.5. Data Analysis 
When analysing data from the elastography phantom, the agreement between ma-
chines was assessed using the percentage difference between cs estimates measured using 
the Aixplorer and using the S2000. The symmetric percentage difference was defined as 
the difference between estimates divided by the mean of the estimates multiplied by 100 
[32] and are reported relative to Aixplorer values, i.e., a positive value indicates that the 
Aixplorer cs estimate was greater than the S2000 cs estimate. There were three values of 
percentage differences in cs, one per observer. Interobserver variability of the cs estimates 
for each inclusion and the background was quantified using the coefficient of variation 
(CV). 
For each in vivo elastogram, mean cs estimate were determined across all measure-
ment locations (up to 6). Median, interquartile range (IQR), maximum and minimum val-
ues of these mean cs estimates were determined for all breasts, for radial and anti-radial 
transducer orientations and for skin, adipose and parenchyma, and for individual sub-
jects. For the Aixplorer this was done twice, including and excluding artefacts. Agreement 
between machine estimates of cs was assessed using symmetric percentage differences in 
cs estimates for each of the variables described above. The correlation between cs estimates 
measured using S2000 and Aixplorer was determined using Pearson’s correlation coeffi-
cient. In addition, the ability of the two machines to record the same contrast in mean cs 
between the skin, adipose and parenchyma tissues was determined using tissue cs ratios: 
skin to parenchyma, skin to adipose and adipose to parenchyma. Anisotropy of cs was 
assessed per breast quadrant using the ratio of the mean cs estimated from the anti-radial 
elastogram to that estimated from the corresponding radial elastogram. 
Statistical analysis was performed with MatLab software (Version 2017a, The Math-
works Inc., Natick, MA, USA). Kolmogorov–Smirnov tests were used to test for normality. 
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Wilcoxon signed-rank tests were used to perform a pair-wise analysis to test for agree-
ment in median of the mean cs estimates, tissue cs ratios, and anisotropy ratios, between 
the machines. Pair-wise analysis was also performed to test for agreement between mean 
cs estimates obtained using different transducer orientations in the skin, adipose and pa-
renchyma. 
3. Results 
3.1. Difference in cs Estimates between Machines In Vitro 
Representative images of the phantom inclusions acquired using both machines are 
shown in Figure 3b. Table 1 lists the cs estimates in the phantom measured by each ob-
server, symmetric percentage differences cs estimates in between machines, and the nom-
inal values provided by the phantom manufacturer. Aixplorer gave between 0.2% to 
3.06% greater cs estimates than the S2000. The CVs of the cs estimates were <0.1 for all 
regions of the phantom and both machines (see Table 1). Figure 2 shows example images 
of the lesions contained in the phantom acquired using both machines 
Table 1. Individual and mean shear-wave speed (cs) estimates from the Aixplorer and the S2000 and the coefficient of 
variation (CV) of cs estimates across three observers. Individual estimates were the mean of three repeat measurements. 
The means and standard deviations of the symmetric percentage differences are given for each observer in the last column. 
The manufacturer’s nominal cs values for background and inclusions are given. 
 Background Inclusion 1 Inclusion 2 Inclusion 3 Inclusion 4 Mean (SD) 
Nominal cs 2.90 1.60 2.20 3.90 5.20  
Aixplorer: cs estimates (ms−1)  
Observer 1 2.50 2.00 2.60 3.80 4.10  
Observer 2 2.60 1.90 2.50 3.70 4.30  
Observer 3 2.50 1.80 2.50 3.60 4.10  
Mean 2.53 1.90 2.53 3.70 4.17  
CV 0.02 0.05 0.02 0.03 0.03  
S2000: cs estimates (ms−1)  
Observer 1 2.55 1.78 2.50 3.51 4.17  
Observer 2 2.47 1.89 2.40 3.40 4.11  
Observer 3 2.55 1.90 2.49 3.53 4.11  
Mean 2.50 1.90 2.50 3.50 4.10  
CV 0.02 0.04 0.02 0.02 0.01  
Symmetric percentage differences in cs estimates (%)  
Observer 1 −0.99 5.82 1.96 3.97 −0.85 1.98 (2.98) 
Observer 2 2.56 0.26 2.04 4.23 2.26 2.27 (1.41) 
Observer 3 −0.99 −2.70 0.20 0.98 −0.12 −0.53 (1.41) 
Mean 0.20 1.15 1.40 3.06 0.44 1.25 (1.12) 
3.2. Difference in cs Estimates between Machines In Vivo 
A total of 128 elastograms were acquired, 64 for each machine. Ultrasound imaging 
revealed that one volunteer had small dense breasts comprising of mainly parenchymal 
tissue, this volunteer had a maximum imaging depth (skin to pectoral muscles) of approx-
imately 2 cm. The other three volunteers had breasts of various sizes with differing 
amounts of adipose and parenchymal tissues, the maximum imaging depths in these vol-
unteers were greater than 4 cm. Artefacts of ill-defined vertical bands of higher cs than the 
average, appearing at approximately regularly spaced lateral intervals (as in Figure 3a, 
were observed in 100% of Aixplorer elastograms. In two Aixplorer images, artefacts cov-
ered the entire skin and adipose regions, and cs estimates from regions without artefacts 
could not be obtained. In five Aixplorer elastograms, the elastogram-overlay box was in-
correctly positioned below the outermost layer of the skin and cs in the skin could not be 
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obtained. A gel stand-off was clearly visualised on 96% of Aixplorer images and 100% of 
S2000 images. In two volunteers, the B-mode image did not clearly differentiate adipose 
tissue from the parenchyma. In these volunteers, cs estimates were obtained in skin and 
parenchyma only. 
Figure 4a illustrates that shear-wave speed estimates were significantly greater when 
measured using Aixplorer (avoiding artefacts) compared to S2000 in all tissue types (p-
values < 0.001). Symmetric percentage differences in median cs estimates between ma-
chines were 40.0%, 50.0% and 51.4% for skin, adipose and parenchyma tissues, respec-
tively. The variance of Aixplorer mean cs estimates was also statistically significantly 
greater than the variance of S2000 estimates (p-values < 0.001) in all tissues. The median 
and IQR of the mean cs estimates were significantly less when measured excluding arte-
facts in the skin and adipose (p-values < 0.001) and gave better agreement with S2000 cs 
estimates. All subsequent Aixplorer data presented were determined using cs estimates 
measured avoiding artefacts. Pearson correlation coefficients between cs estimates meas-
ured using individual elastograms acquired using S2000 and Aixplorer in the skin, adi-
pose and parenchyma were 0.25, 0.15 and 0.33 and were not statistically significant (p > 
0.05). When cs estimates were averaged over the whole breast (eight elastograms) Pearson 
correlation coefficients were 0.16 (p = 0.5), 0.75 (p = 0.057) and 0.75 (p << 0.01), respectively. 
All data are tabulated in Table 2. 
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Figure 4. Showing: (a) Shear-wave speed (cs) estimates for skin, adipose and parenchyma using Aixplorer (excluding ar-
tefacts) and S2000, and; (b) cs estimates for skin, adipose and parenchyma measured using Aixplorer including and ex-
cluding artefacts. Median is illustrated by the central horizontal bar; the horizontal box edges show the IQR and the whisk-
ers (dashed lines) show the range. Range is defined by adjacent values, which are the 25th or 75th quartile plus or minus 
the IQR multiplied by 1.5. Opposing triangles illustrate the 95% confidence interval on the median cs and ‘+’ indicates an 
outlier (any value outside the adjacent values). *** indicates where machine cs estimates were significantly different with 
p-value < 0.001. 
Table 2. Median, Interquartile range (IQR) max and mean shear-wave speed (cs) estimates from the 
Aixplorer and the S2000 across all elastograms measured in skin adipose and parenchyma. S = skin, 
A = adipose and P = parenchyma. 
 Mean cs estimate per elastogram (ms-1) 
 Aixplorer Aixplorer (with artefacts) S2000 
 S A P S A P S A P 
Median 2.4 2.0 2.2 3.0 2.9 3.0 1.6 1.2 1.3 
IQR 0.9 0.4 0.6 0.9 0.4 0.6 0.3 0.3 0.3 
Max 3.5 2.7 2.8 4.0 4.1 3.2 2.4 1.8 2.1 
Min 1.6 1.5 1.2 1.8 1.9 1.2 1.2 1.0 1.0 
3.3. Comparison of Tissue cs Ratios between Machines 
Figure 5 provides a box and whiskers plot of tissue cs ratios per elastogram for both 
machines. For both machines, all median tissue cs ratios were statistically significantly 
greater than unity, indicating that, on average, the skin had greater cs than parenchyma 
and adipose tissues, and parenchyma had greater cs than adipose tissue. There was no 
statistically significant difference in median tissue cs ratios between machines. 
 
Figure 5. Tissue cs ratios measured in skin, adipose and parenchyma in individual elastograms of 
the breast using Aixplorer and S2000. (See Figure 2 caption for full explanation of box plot). 
Aixplorer data were acquired using ROIs that did not include artefacts. The IQR and range may be 
influenced by variation between volunteers, breast quadrants and transducer orientation. ** or *** 
indicates where median cs estimates for different tissue types were significantly different with p-
value < 0.01 or < 0.001, respectively. 
3.4. Comparison of Anisotropy Ratios between Machines 
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Figure 6 gives the median, IQR and range of anisotropy ratios for individual breast 
quadrants. Mean cs estimates (per elastogram) were statistically significantly greater when 
the transducer was placed in an anti-radial orientation for all tissues and both machines 
except for estimates measured using Aixplorer in skin. When cs estimates were averaged 
over the whole breast for anti-radial and radial positions, only for the S2000 did anti-radial 
cs estimates remained statistically significantly higher than radial cs estimates. 
 
Figure 6. Anisotropy ratios (ratio of mean anti-radial cs to mean radial cs in individual pairs of elas-
tograms obtained at the same location in the same breast quadrant on the same breast in the same 
individual) measured in skin, adipose and parenchyma for Aixplorer and S2000. *, ** or *** indicates 
where median cs estimates for anti-radial and radial transducer orientations were significantly dif-
ferent with p-value < 0.05, < 0.01 or < 0.001, respectively. 
4. Discussion 
4.1. Difference in cs Estimates between Machines In Vitro 
Two studies have compared Siemens S2000 (or S3000) point SWE (pSWE) or 2D-SWE 
and Aixplorer cs estimates in vitro using the same transducers that were used in the current 
study [15,18]. Using a phantom with nominal cs ≈ 2.3 ms−1 Shin et al. [15] found S2000 
pSWE gave statistically significantly lower cs estimates than Aixplorer by 0.1 ms−1 and 0.4 
ms−1 at depths of 3.0 cm and 4.0 cm, respectively. Dillman et al. [18] compared S3000 pSWE 
with S3000 2D-SWE and Aixplorer 2D-SWE, at depths of 1.0, 2.5 and 4.0 cm in soft (cs ≈ 0.9 
ms−1) and hard (cs ≈ 2.1 ms−1) phantoms and found small (<0.2 ms−1) statistically significant 
differences between them, however, no consistent bias between machines was observed. 
Hall [14] compared S2000 pSWE and Aixplorer 2D-SWE using curvilinear transduc-
ers at depths of 3.0, 4.5 and 7.0 cm across multiple machines at multiple sites. The 
Aixplorer gave significantly greater cs estimates than the S2000, by up to ~0.2 ms−1 in a soft 
phantom (cs ≈ 1.0 ms−1). However, the use of a phased array transducer with the S2000 at 
one of the test sites may have biased the results; the S2000 cs estimates at that site were 
significantly lower than the S2000 estimates at the other 4 sites. There was no statistically 
significant difference between the two machines in mean cs estimates in a harder phantom 
(cs ≈ 2.1 ms−1). Similar to the above studies, the phantom data obtained in this study re-
vealed only small differences in cs between the machines, which were on the order of the 
interobserver variation. Estimates were obtained at a depth of 1.5 cm using linear trans-
ducers for both systems and therefore no bias due to depth or transducer geometry was 
expected. 
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4.2. Rationale for the Exclusion of Artefacts from Aixplorer Elastogram Analysis 
All Aixplorer shear-wave elastograms obtained in vivo contained artefacts that ap-
peared to correspond with the position of the acoustic radiation force beams; they moved 
with the lateral translation of the transducer and their number varied with the lateral size 
of the elastogram box. Artefacts were also observed in vitro and were most clearly visual-
ised in the two stiffer inclusions. Across all volunteers, Aixplorer cs estimates (including 
artefacts) in adipose tissues were significantly greater than cs estimates in parenchyma 
(Figure 4b, which was contrary to what has been reported in the literature. When artefacts 
were excluded the findings of the current study agreed with three large (minimum num-
ber of women 89) clinical studies that measured cs in normal breast tissue using S2000 2D-
SWE and found that breast parenchyma had statistically greater cs than adipose tissue [26–
28]. In addition, Athanasiou et al. [33] found similar results using Aixplorer in 46 women. 
On visual examination of the elastograms, artefacts appeared most intense (greater 
cs) below the gel-skin and skin-adipose interfaces. ‘Artefactual vertical bands of stiffness’ 
were observed by Berg et al. [34] in their study of breast lesions using Aixplorer 2D-SWE. 
Berg et al. [34] attributed these artefacts to tissue compression and noted they were diffi-
cult to avoid at superficial depths despite using large amounts of ultrasonic gel and a no-
compression scanning protocol. We concluded that cs estimates obtained in regions with 
artefacts were less reliable and only data from regions that were free from artefacts were 
used for subsequent analysis of anisotropy ratios. 
4.3. Difference in cs Estimates between Machines In Vivo 
This study found that in vivo, S2000 cs estimates were on average less than cs estimates 
obtained using the Aixplorer. The differences between machines were greater in vivo than 
in vitro, with a maximum cross-machine cs-ratio of 1.70 in vivo compared to 1.07 in vitro. 
To the authors’ knowledge, this is the first study comparing cs estimates of different elas-
tography machines in the normal breast in vivo. Furthermore, cs estimates between ma-
chines were uncorrelated except for cs estimates for parenchyma averaged across the 
whole breast. The observed bias and poor correlation between machines exclude the use 
of an absolute measure of breast stiffness such as cs or Young’s Modulus, i.e., a simple 
value of breast stiffness would not be reproducible between centres. Further studies com-
paring these machines are required to determine if these biases can be corrected to provide 
consistent measures of breast tissue between centres. It is important to note that there were 
large differences in the variation between machines observed in vitro and in vivo. It ap-
pears from the data presented here that phantom studies would not be adequate to pro-
vide data for cross-calibrations of machines. 
Several studies have compared liver cs measured using 2D-SWE and pSWE in vivo 
[17,35–37] using a range of different commercially available pSWE and 2D-SWE machines 
and found that 2D-SWE and pSWE could not be used interchangeably to grade the sever-
ity of liver fibrosis in patients with liver disease. Ferraioli et al. [20] also compared two 
2D-SWE machines (Aixplorer and Aplio 500 (Canon/Toshiba, Japan)) in 21 patients with 
liver disease. The mean difference between the two 2D SWE machines was −0.6 ms−1 and 
95% LOA −1.4 ms−1 and 1.2 ms−1; which of the machines gave the greatest cs estimate was 
not reported. 
Differences between cs measured by different machines may, in part, be due to dif-
ferences in the frequency content of the shear-waves. This would be consistent with our 
observation that such differences are greater for measurements in tissue than in phantoms 
since tissue is likely to possess increased shear wave dispersion due to viscoelastic damp-
ing or scattering of the shear wave relative to that in the phantom. Furthermore, it is pos-
sible that the way in which the ARFI pushing beams are executed, as described in the 
introduction, may result in different shear wave frequencies. Even with similar shear-
wave bandwidth, if, to estimate cs, vendors rely on a model of shear-wave propagation 
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that assumes the spatial and temporal characteristics of the acoustic radiation force im-
pulse (ARFI) push and the elastic or viscoelastic properties of the tissue, differences in 
models may result in differences in estimated cs. It is also feasible that differences between 
machines arise due to differences in the ways in which their respective measurements of 
shear-wave speed are affected by the region within the lateral boundaries of the ARFI 
pushing beam, where a direct and immediate displacement from the ARFI push, whose 
magnitude decays with off-axis distance according to the ARFI intensity beam profile, is 
summed with the spatiotemporally varying displacement due to the propagating shear 
wave. 
Further work is required to improve our understanding of the cause of machine bias 
and why it appears to be greater in tissue than in current phantoms. Nevertheless, even if 
standardisation of the frequency content of shear wave pulses used in SWE is not feasible, 
it would be helpful if manufacturers were able to provide the shear-wave frequency spec-
trum generated in typical tissues at a number of imaging depths, as part of the machine 
specification, so that authors could incorporate the information into publications such as 
this, as called for by Dietrich et al. [38]. 
4.4. Comparison of Tissue cs Ratios and Anisotropy Ratios between Machines 
For both machines, tissue cs ratios were greater than unity indicating that skin had 
higher cs estimates than parenchyma, and parenchyma had higher cs estimates than adi-
pose tissue. No significant differences in any tissue cs ratios between machines were de-
tected, suggesting that whilst the machines differed in absolute values of cs estimates, rel-
ative values between tissue types are similar. 
Zhou et al. [28] reported anisotropy ratios (radial to anti-radial) of 1.28 and 1.30 in 
adipose and parenchyma tissue in the normal breasts of 137 patients, respectively, meas-
ured using S2000 pSWE. These findings were consistent with the radial orientation of 
ducts and Cooper’s ligaments and that material properties of the tissue are dependent on 
the orientation of tissue fibres. For example, Kruse et al. [39] and Gennisson et al. [40] in 
observations of muscle, and Coutts et al. [41] and Coutts et al. [42] in observations of skin, 
found that shear modulus and stiffness vary according to the direction of shear wave 
propagation and strain respectively, with respect to the muscle or dermal collagen fibres, 
and that cs and stiffness were greatest when measured parallel to the fibres. 
The current study detected a difference between cs estimates measured in the radial 
and anti-radial orientations. The effect, however, was the reverse of that observed by Zhou 
et al. [28], with greater cs measured with the transducer in the anti-radial orientation. The 
reason for this is unknown, although it may be significant that Zhou et al. [28] measured 
the cs only at a single point with the probe in both orientations. The current study, which 
used a much smaller number of volunteers, compared average cs across many measure-
ment points in each image plane. The exact same volume of tissue was not being interro-
gated in each orientation, nor was the shear wave propagation direction truly anti-radial 
for any points other than at the central beamlines of the anti-radial scan, which may ac-
count for the different findings. For a direct comparison with the findings of Zhou et al., 
[28], a modification of our experimental method would be required, but this would be 
contrary to the objective of our study as discussed below. 
The differences in cs estimates between transducer orientations indicate that one or 
both transducer orientations should be used to acquire cs estimates. Care should be taken 
to acquire data in the correct orientation, and perhaps this can be performed with refer-
ence to anatomical landmarks such as the nipple. The focus of the current study is the 
comparison of the machines for their ability to pool data, and the observed anisotropy in 
cs estimates, although not consistent with the findings of Zhou et al. [28], was consistent 
between machines. This may suggest bias in the measurement technique, for example, a 
change in gel stand-off between the different transducer orientations, however, no sys-
tematic differences in gel stand-off between the images acquired using radial and ant-
radial orientations was observed. 
Appl. Sci. 2021, 11, 9391 13 of 16 
 
In the context of the future measurement of radiation toxicity to the breast and the 
use of the unirradiated breast as a reference measure of cs, large variation in relative cs 
estimates between normal breasts between machines would reduce the sensitivity of 2D-
SWE to detect a change in stiffness in the breast due to radiation-induced fibrosis, i.e., any 
radiation-induced change in cs, whether absolute or relative to the unirradiated breast, 
should be significantly greater than the equivalent natural variation in the population of 
women receiving radiotherapy for breast cancer. The magnitude of the effect of radiation 
on cs in the tissues of the breast is as yet unknown. This cohort of volunteers is too small 
to investigate the underlying natural variation between breasts, however, we have ob-
served large variation in shear wave speeds between samples (Figure 4) and patients. En-
couragement that it may be possible to use cs for this purpose can be gained from the 
observations that semi-quantitative strain elastography using a calibrated stand-off pad 
demonstrated in all three of three patients who had received radiotherapy to the breast 
some years earlier, the irradiated breast had a higher Young’s modulus that the unirradi-
ated breast [43], and even subjective palpation is capable grading the level of breast stiff-
ness changes that are caused by radiation damage and of distinguishing between the ir-
radiated and unirradiated breast [1]. If the effect is smaller than the average variation be-
tween patients, it may be possible to use the contralateral breast as a reference or acquire 
a baseline (pre-treatment image) to measure the change in stiffness. 
4.5. Limitations of This Study 
A limitation of this study is the small number of volunteers. To compare SWE ma-
chines a cross-centre study had to be performed, which limited the number of volunteers 
available. Despite the small number of volunteers, differences in cs estimates between ma-
chines were significant and consistent for all breasts and all tissue types. This study com-
pared cs estimates between machines in the skin. In skin, and othered layer tissue, such as 
the cornea, shear waves may be guided modifying the cs and introducing dispersion [44] 
and the relationship between cs and the elastic modulus can no longer be simply approx-
imated by E = 3cs2. Variation in the skin boundary conditions may also affect cs [40]. Pre-
vious studies of 2D-SWE in skin have controlled for this effect. To investigate the relative 
stiffness of sclerotic and normal skin the relative cs of sclerotic and normal skin was nor-
malised by the ratio of skin thicknesses [45–47]. Similarly, in a study of the corneal colla-
gen cross-linking using the Aixplorer, direct comparison of the stiffness of corneas with 
and without collagen cross-linking was justified by monitoring the central cornea thick-
ness and ensuring there was no difference in cornea thickness between paired measure-
ments [48]. In this work, cross-machine comparisons of cs with the transducer in the same 
position on the breast were made and therefore skin thickness will be the same for both 
measurements. For future studies of radiation-induced breast toxicity using 2D-SWE, rel-
ative measures of radiation-induced skin toxicity that rely on comparison with the con-
tralateral breast should consider variations in skin thickness and boundary conditions 
[45]. Another limitation is the use of a different operator to acquire in vivo data from each 
machine, which may introduce bias in cs estimates. We also expect that interoperator var-
iation may contribute to the poor correlation overserved between the elastograms ac-
quired with different machines but of the same tissue sample. A further source of varia-
tion may be the placement of the probe on the breast, including changes in orientation. 
We used a surgical marker pen to mitigate against this variation, however, we expect that 
the heterogeneous nature of the breasts means that a small variation in probe placement 
could result in a small variation in cs between scans. However, our use of two operators 
was by design, because it mimics the way that data would be acquired in a future multi-
centre study, it was expected that interoperator variation, which includes variations in 
probe placement, to be a small effect. Studies report good agreement between operators 
both in vitro and in vivo [14,19,20,37] and care was taken to give the two radiologists the 
same instructions and to allow them to practice data acquisition using a phantom. 
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5. Conclusions 
Differences in cs estimates between 2D-SWE machines were much greater in vivo than 
in vitro. Aixplorer gave a greater estimate of cs than S2000 in all tissues. Differences in cs 
estimates limit the use of absolute measures of cs as a quantitative biomarker in cross-
centre studies unless this bias can be reliably corrected. Shear-wave speed estimates must 
be acquired using the same transducer orientation across centres and across machines. 
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